The protective efficacy of chlamydial protease-like activity factor vaccination is dependent upon CD4+ T cells. | Profiles RNS

RCMI Coordinating Center (RCMI CC)

The protective efficacy of chlamydial protease-like activity factor vaccination is dependent upon CD4+ T cells.

Murphey C, Murthy AK, Meier PA, Neal Guentzel M, Zhong G, Arulanandam BP. The protective efficacy of chlamydial protease-like activity factor vaccination is dependent upon CD4+ T cells. Cell Immunol. 2006 Aug; 242(2):110-7.

View in: PubMed

authors with profiles

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support